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ABSTRACT 
Background: Homologous blood transfusion carries a well-documented 
array of risks especially in an HIV endemic environment like Nigeria. It 
is therefore imperative to consider other forms of restoring blood 
volume in surgical patients. Autologous blood transfusion (ABT) is one 
of the ways the problem of HIV transmission can be reduced among 
surgical patients. The knowledge and acceptability of ABT among 
surgical patients about ABT, especially pre-donated ABT were 
assessed. 
 It also assessed whether or not surgeons inform elective surgical 
patients about this alternative 
Materials And Methods 
Questionnaires were distributed among elective surgical patients that presented during the study 
period. The knowledge, willingness and the factors influencing the willingness of the patients to 
participate in ABT were investigated. The data were analyzed with SPSS Version10. 
Results  
Of the 116 patients [71 males; 45 females] interviewed, 29 (25.0 %) had heard about ABT, 80 (69.0 
%) patients had never heard about ABT while 7 (6.1 %) were not sure. Of the 29 respondents who 
had heard about ABT, only 2 had had ABT. Of the 48 patients who needed blood for current 
surgical problems, only 4 (9.3 %) would have ABT. There was a significant difference in the 
number of respondents who believed that ABT is better than homologous transfusion (x2 = 69.11, p 
< 0.001). 
Conclusion 
The knowledge of ABT is low among our surgical patients and surgeons should present this 
alternative to their patients. The acceptance of ABT may also help in reducing or eliminating HIV 
transmission via blood transfusion.  
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arious detrimental effects of 
homologous blood transfusion have 
been documented1. Annually, donor 
blood is responsible for 300,000 cases of 
hepatitis and 15,000 cases of cirrhosis2. Three 
percent of the documented AIDS cases in the 
United States have been linked to the 
contaminated blood donor.  
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Using the patient’s own blood eliminate the 
risk of the patient contracting hepatitis, AIDS, 
cirrhosis or other infections through 
contaminated homologous blood transfusion3. 
Apart from this, homologous blood 
transfusion is a finite resource and in Nigeria 
blood transfusion is associated with chronic 
blood shortage because Nigerians are 
unwilling to donate voluntarily. Autologous 
blood may therefore be a saving grace to 
many elective patients. But do our patients 
know about this alternative? Are they willing 
to accept it?. What are their fears concerning 
this method of transfusion? These are the 
questions this paper is set to answer. 
 
V 
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Materials And Method   
A prospective study was carried out to assess 
the knowledge of, and willingness of elective 
surgical patients to accept autologous 
blood.questinaionaires were distributed 
among surgical patients who presented to the 
surgical outpatient clinic and those admitted 
to have elective surgical procedures at the 
Ladoke Akintola University of Technology 
Teaching hospital, Osogbo, Osun State, 
Nigeria. Ethical clearance and consent of the 
patient were obtained. The biodemographic 
data were collected. Other information 
collected included the clinical diagnosis in 
each patient. The patients were then asked of 
their knowledge about blood transfusion, 
autologous blood transfusion and whether or 
not they would accept this method of 
transfusion. The data were collated and then 




A total of 116patients from various surgical 
specialties took part in this study. There were 
71(61.2%) males. Their ages ranged between 
14 and 75 years with a mean (±SD) of 38.85% 
(±16.87) years. The specialties were shown in 
table 1 with Orthopaedic surgery contributing 
the highest percentage of 28(27.2%), followed 
by 27(26.2%) from general surgery, and the 
least 3(2.9%) being from Urology. 
 
Table 1. Association between specialty and willingness to participate in ABT. 
 
Patients Specialty Willingness to have ABT 
  Yes No Not sure 
General surgery 27(26.2%) 14(51.9%) 7(25.9%) 6(22.2%) 
Plastic surgery. 13(12.6%). 11(84.6%) 1(7.7%) 1(7.7%) 
Ortho..Surg. 28(27.2%). 11(39.3%) 6(21.4%) 11(39.3 
Neurosurgery 6(5.8%) 3(50%) 2(33.3) 1(16.7%) 
ENT 4(3.9%) 4(100%) -- -- 
Urology 3(2.9%) 1(37.3) -- 2(66.7%) 
Ophthalmology 5(4.9%) 2(40.0%) -- 3(60.0%) 
Gynaecology 9(8.7%) 6(66.7%) 2(22.2%) 1(11.1%) 
Others 21(18.1%) 5(23.8%) 3(14.3%) 13(61.9%) 
TOTAL 116(100%) 57(49.1%) 21(18.1%) 25(21.6%) 
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One hundred and two  (87.9%) of the patients 
had heard about blood transfusion before, 
with 13(1.2%) who had however heard and 
1(0.9%) who was not sure. Only 29(25.0%) of 
the respondents had however heard about 
ABT before while 80(69.0%) of the patients 
had never heard and 7(6.1%) were not sure. 
Thirty-nine (33.6%) of the patients had had 
blood transfusion before, while 77(66.4%) 
had never been transfused. Of the 39 patients 
who had had blood transfusion, only 2(1.7%) 
had ABT, 9(7.8%) and 16 (13.8%) had their 
spouses and siblings respectively donating for 
them, 2(1.7%) had their fathers donating for 
them, 1(0.9%) had his child donating for him 
while 9(7.7%) were transfused with blood 
from donors who were neither related to them 
nor known to them. 
For their current clinical problems, 48(41.4%) 
of them had been told they needed blood for 
the procedures while 54(46.6%) did not need 
blood and 5(4.3%) were not sure they would 
need blood transfusion at the time of the 
interview. Of the 48 patients who needed 
blood for their current Surgical problems, 
4(9.3%) would have autologous blood, 
7(16.3%) would have blood donated to them 
by their spouses while 21(48.8%) and 
17(39.5%) of the patients respectively would 
have blood donated by their siblings and 
unknown donors. 
Significant number of the respondents, 
73(62.9%) agreed that ABT is better and 
54(74.0%) of these were willing to predonate 
compared to 14(13.6%) who felt ABT is not 
as good as homologous blood; 11(10.7%) of 
who were not willing to personate. This is 
statistically significant (Chi2 =69.11, p, 
0.001)(Table 2). 
 
Table 2.  Association between knowledge that “own blood” is better and willingness to have ABT 
 
 
Knowledge that own blood is 
better 
Willingness to have ABT 
  Yes No Not sure 
Yes 73(62.9%) 54(74.0%) 7(9.6%) 12(16.4%) 
No 14(12.1%) -- 11(8.6%) 12(16.4%) 
Not sure    29(25.0%) 3(10.3%) 3(10.3%) 23(79.3%) 
TOTAL 116(100%) 57(49.1%) 21(18.1%) 38(21.6%) 
Chi 2=69.11, P=0.005 
 
 
Fifty-nine (50.9%) of the respondents would 
want to have if told by their surgeons they 
needed it, thirty one (26.7%) would not, while 
26. (22.4%) were not sure they would. 
Appreciable number of the patients agreed to 
participate in ABT with the highest among 
ENT patients 4 (100%), followed by plastic 
surgery, 11(84.6%) and least among urology 
patients with 1(37.3%), though this is not 
statistically significant (chi2 =23.83,p=0.093). 
When asked for the advantages of Autologous 
blood compared to homologous blood, 
25(21.6%) of the respondents felt there would 
be reduced risk of infections, 12(10.3%) 
reduction in transfusion reaction, 2(1.7%) 
patients felt it was cheaper, 8(6.9%) felt it 
was psychologically more gratifying while 
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one(0.9%)patient felt it would hasten the time 
to have the elective surgery done. Many, 
49(48.5%) of the respondents felt that 
predonation of blood is not hazardous and 
43(87%) were willing to pre-donate, 
compared to only 7(33.3%) of the 12(57.1%) 
who believed it was hazardous and were not 
willing to take part in ABT. This is 
statistically significant (Chi2=63.01,P=0.001) 
(Table 3).  
The possible hazards outlined by the patients 
that could result from Autologous blood 
include blood shortage /shock, 15(12.9%) 
delayed recovery in 3(2.6%), 3(2.6%) felt 
they would develop some sicknesses while 
one (0.9%) felt it could lead to death. 
   Of 31 patients who would not like 
autologous blood, only 9(12.7) gave reasons 
and they include 5(7.0%) who felt their blood 
may not be sufficient; 2(2.8%) believed 
predonating may cause ill heath, 1(1.4%) felt 
other option of homologous blood is better, 
1(1.4%) was of opinion he might lose much 
blood during surgery and would therefore not 
want to donate. 
 
 
Table 3. Suggestion that ABT is hazardous and willingness to have ABT 
 
ABT is hazardous Willingness to have ABT 
  Yes No Not sure 
Yes 21(20.8%) 7(33.3%) 2(57.1%) 2(9.5%) 
No 49(48.5%) 43(87.7%) 3(6.1%) 3(6.1%) 




Since the discovery of human blood groups 
by Landsteiner in 1900 major advances in 
transfusion medicine have occurred, making 
current blood supply safer and safer. 
However, the risk will never be zero4. The 
safest blood a person can receive is his own. 
Many microorganisms can be transmitted 
through transfusion 5. Public fears of 
transfusion transmitted diseases, particularly 
the Human Immunodeficiency Virus (HIV), 
has prompted an increasing demand by 
patients for their own blood to be collected 
and stored for elective surgery, thus 
eliminating all risk of infection or 
immunization to donor antigens6 The number 
of institutions offering these programs 
increased 16-fold from 1970 to 1981, 
according to an American Association of 
Blood Banks (AABB) survey7. Acceptance by 
clinicians and patients has grown steadily  
 
since then in America. Our patients in this 
part of the world do not know that this is a 
feasible alternative as only 29(87.9%) of our 
patients had heard about this alternative even 
though most, 102(87.9%) of the respondents 
had heard about blood transfusion generally. 
ABT had been observed to be capable of 
relieving blood crisis in the nation and that 
transfusion of the patient’s own blood is 
standard in many surgical procedures8. The 
most common form of ABT is where blood is 
donated in anticipation of elective surgery9. In 
our patients however, predonation of blood 
for elective surgery is not a common practice.  
This is evident in the fact that of the 48 
patients who needed blood for their current 
clinical problems, only 4(9.3%) would have  
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autologous blood by predonating while others 
would have homologous blood from the bank. 
Autologous blood has been used in several 
centres under varying circumstances.10-12 
Only 48(41.4%) of the patients responded to 
suggest correct possible advantages of ABT.  
Although a large number, 62(53.4%), of the 
patients felt there was no significant risk in 
donating their own blood, not all of the 
respondents were willing to have ABT. 
However of 31 patients who would not like 
Autologous blood, only 9(12.7%) gave 
reasons which means that majority of the 
patients did not have any genuine reason(s) 
for rejecting Autologous blood. 
It is obvious from this study that the practice 
of autologous blood transfusion in our 
environment is quite low and many of our 
patients don’t know about autologous blood 
transfusion.  Although only 29(25.0%) of the 
patients had heard about autologous blood 
transfusion, an increased number, 59(50.9%) 
of the respondents would like to have this 
alternative if given by their surgeons when 
they needed blood transfusion for surgery.  It 
is obvious that the responses to the 
advantages and the disadvantages of 
Autologous blood transfusion were correct in 
listing some of these advantages and possible 
adverse effects of the procedure. 
It is noted from the study that patients’ 
knowledge that their own blood is better and 
the consciousness of hazards of homologous 
blood transfusion influence their willingness 
to predonate and this was statistically 
significant (P< 0.001) respectively. 
Our conclusion is that surgeons need to 
inform patients about these alternatives in 
blood transfusion and their advantages.  This 
will lead to an improved willingness on the 
part of our patients to choose autologous 
blood if and when the physicians inform and 
educate them on this. This practice will also 
go a long way towards preventing the current 
spate of HIV/AIDS among surgical patients  
 
 
and will reduce the load currently placed on 
homologous blood. Improved education 
regarding transfusion alternatives, along with 
collaboration from all involved disciplines, 
will help achieve the goal of minimizing the 
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